A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Bone Marrow Transplantation

• Publication date

  2002-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.bmt.1703394PMID 11919725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation.

  2001cited by this paper
• Mechanism and Amelioration of Recombinant Human Interleukin‐11 (rhIL‐11)–Induced Anemia in Healthy Subjects

  2000cited by this paper
• The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.

  2000cited by this paper
• Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters.

  2000cited by this paper
• Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants.

  1999cited by this paper
• Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.

  1998cited by this paper
• A randomized trial of recombinant human interleukin-11 following autologous bone marrow transplantation with peripheral blood progenitor cell support in patients with breast cancer.

  1998cited by this paper
• Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.

  1997cited by this paper
• Interleukin-12 prevents severe acute graft-versus-host disease (GVHD) and GVHD-associated immune dysfunction in a fully major histocompatibility complex haplotype-mismatched murine bone marrow transplantation model.

  1997cited by this paper
• IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE

  1997cited by this paper
• Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis.

  1997cited by this paper
• Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters.

  1997cited by this paper
• Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.

  1997cited by this paper
• A clinical phase I/II study of recombinant human interleukin-1 receptor in glucocorticoid-resistant graft-versus-host disease.

  1996cited by this paper
• Interleukin-11 induces intestinal epithelial cell growth arrest through effects on retinoblastoma protein phosphorylation.

  1996cited by this paper
• Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation.

  1996cited by this paper
• Protection of the Small Intestinal Clonogenic Stem Cells from Radiation‐Induced Damage by Pretreatment with Interleukin 11 also Increases Murine Survival Time

  1996cited by this paper
• Interleukin-12 inhibits murine graft-versus-host disease.

  1995cited by this paper
• Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11.

  1995cited by this paper
• Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease.

  1995cited by this paper
• 1994 Consensus Conference on Acute GVHD Grading.

  1995cited by this paper
• Interleukin‐11 protects the clonogenic stem cells in murine small‐intestinal crypts from impairment of their reproductive capacity by radiation

  1995cited by this paper
• Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha

  1995cited by this paper
• TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD.

  1995cited by this paper
• Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease.

  1994cited by this paper
• Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease

  1994cited by this paper
• A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy.

  1994cited by this paper
• A study of cytokine production in acute graft-vs-host disease.

  1991cited by this paper
• Demonstration of direct involvement of cytokines in graft-versus-host reactions using an in vitro human skin explant model.

  1991cited by this paper
• The role of keratinocyte cytokines in inflammation and immunity.

  1990cited by this paper
• In vivo and in vitro production of IFN-beta and IFN-gamma during graft vs host disease.

  1988cited by this paper
• Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

  1987cited by this paper
• “Model”

  1981cited by this paper
• Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

  1980cited by this paper

• Graft-Versus-Host Disease Mouse Models: A Clinical-Translational Perspective.

  2025cites this paper
• Immune mediators as therapeutic targets in GvHD; cytokines, growth factors, chemokines, and co-stimulation /co-inhibition.

  2025cites this paper
• Interleukin Networks in GVHD: Mechanistic Crosstalk, Therapeutic Targeting, and Emerging Paradigms

  2025cites this paper
• Managing strategies of chemotherapy and radiotherapy-induced oral mucositis.

  2025cites this paper
• HC-HA/PTX3 from Human Amniotic Membrane Induced Differential Gene Expressions in DRG Neurons: Insights into the Modulation of Pain

  2024cites this paper
• The safety and efficacy of interleukin 11 for radiation injury

  2023cites this paper
• A prospective interventional study of recombinant human interleukin-11 mouthwash in chemotherapy-induced oral mucositis

  2022cites this paper
• Donor T cell DNMT3a regulates alloreactivity in mouse models of hematopoietic stem cell transplantation

  2022cites this paper
• The Pathophysiology and Treatment of Graft-Versus-Host Disease: Lessons Learnt From Animal Models

  2021cites this paper
• Effect of Keratinocyte Growth Factor on Hospital Readmission and Regimen-Related Toxicities after Autologous Hematopoietic Cell Transplantation for Lymphoma.

  2021cites this paper
• Predictive Model and Precaution for Oral Mucositis During Chemo-Radiotherapy in Nasopharyngeal Carcinoma Patients

  2020cites this paper
• Predictive Model for Oral Mucositis of Nasopharyngeal Carcinoma Patients Receiving Chemo-radiotherapy

  2020cites this paper
• Interventions to prevent suicidal behavior and ideation for patients with cancer: A systematic review.

  2019cites this paper
• T Cell– and B Cell–Mediated Pathology in Chronic Graft-Versus-Host Disease

  2019cites this paper
• Animal models of chemotherapy-induced mucositis: translational relevance and challenges.

  2018cites this paper
• Challenges in the local delivery of peptides and proteins for oral mucositis management

  2018cites this paper
• Animal Models for Preclinical Development of Allogeneic Hematopoietic Cell Transplantation.

  2018cites this paper
• Acute Renal Graft-Versus-Host Disease in a Murine Model of Allogeneic Bone Marrow Transplantation

  2017cites this paper
• Palifermin for oral mucositis after intensive therapy for hematologic cancers

  2017cites this paper
• Cyclin-dependent kinase 5 activity is required for allogeneic T-cell responses after hematopoietic cell transplantation in mice.

  2017cites this paper
• Acute renal graft-versus-host disease in a murine model of allogeneic bone marrow transplantation.

  2017cites this paper
• Oral Mucosa Dose Parameters Predicting Grade ≥3 Acute Toxicity in Locally Advanced Nasopharyngeal Carcinoma Patients Treated With Concurrent Intensity-Modulated Radiation Therapy and Chemotherapy: An Independent Validation Study Comparing Oral Cavity versus Mucosal Surface Contouring Techniques

  2017cites this paper
• Treatment of GVHD by JAK inhibitors

  2017cites this paper
• Impact of dose volume parameters and clinical factors on acute radiation oral mucositis for locally advanced nasopharyngeal carcinoma patients treated with concurrent intensity-modulated radiation therapy and chemoradiotherapy.

  2017cites this paper
• The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview

  2016cites this paper
• A panoramic review and in silico analysis of IL-11 structure and function.

  2016cites this paper
• Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?

  2016influential citation
• Insights into the pathogenesis of GvHD: what mice can teach us about man.

  2015cites this paper
• IL-11 signaling as a therapeutic target for cancer.

  2015cites this paper
• Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors.

  2015cites this paper
• This information is current as Cytokines in Graft-versus-Host Disease

  2015cites this paper
• Various Forms of Tissue Damage and Danger Signals Following Hematopoietic Stem-Cell Transplantation

  2014cites this paper
• Oral Complications in Hematopoietic Stem Cell Recipients: The Role of Inflammation

  2014cites this paper
• ADVANCES IN HEMATOPOIETIC CELL TRANSPLANTATION The biology of graft-versus-host disease: experimental systems instructing clinical practice

  2014cites this paper
• Pleurisy as a novel clinical manifestation associated with human herpesvirus 6 after unrelated cord blood transplantation

  2014cites this paper
• Local and Systemic Pathogenesis and Consequences of Regimen-Induced Inflammatory Responses in Patients with Head and Neck Cancer Receiving Chemoradiation

  2014cites this paper
• The biology of graft-versus-host disease: experimental systems instructing clinical practice.

  2014cites this paper
• Effect of topical chamomile on immunohistochemical levels of IL-1β and TNF-α in 5-fluorouracil-induced oral mucositis in hamsters

  2013cites this paper
• Emerging evidence on the pathobiology of mucositis

  2013cites this paper
• B and T cells in chronic graft-versus-host disease and graft-versus-leukemia

  2013cites this paper
• Emerging evidence on the pathobiology of mucositis

  2013cites this paper
• Pathobiology of Cancer Regimen-Related Toxicities

  2013cites this paper
• Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients

  2012cites this paper
• Intestinal Graft-Versus-Host Disease

  2012cites this paper
• Advances in Stem Cell Research

  2012cites this paper
• Cellular Therapy for Hematology Malignancies: Allogeneic Hematopoietic Stem Transplantation, Graft-Versus-Host Disease, and Graft Versus Leukemia Effects

  2012cites this paper
• Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatments

  2011cites this paper
• The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells

  2011cites this paper
• Prevention of GVHD without losing GVL effect: windows of opportunity

  2011cites this paper
• Interventions for preventing oral mucositis for patients with cancer receiving treatment.

  2011cites this paper
• Direct Conversion of Skin Cells into Blood : Alchemy or Science ?

  2011cites this paper
• Is Human Cell Therapy Research Caught in a Mousetrap

  2011cites this paper
• Is human cell therapy research caught in a mousetrap?

  2011cites this paper
• [Therapeutic effects and mechanism of saikosaponin-d in mice with bleomycin-induced pulmonary fibrosis].

  2010cites this paper
• Interleukin-10 and -12 Predict Chemotherapy-Associated Toxicity in Esophageal Adenocarcinoma

  2010cites this paper
• Serum amyloid P ameliorates radiation-induced oral mucositis and fibrosis

  2010cites this paper
• Interventions for treating oral mucositis for patients with cancer receiving treatment.

  2010cites this paper
• Pharmacologic Prevention of Acute Graft‐Versus‐Host Disease

  2009cites this paper
• Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects.

  2009cites this paper
• Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.

  2009cites this paper
• Selective effects of cyclosporine a on Th2-skewed dendritic cells matured with viral-like stimulus by means of toll-like receptors.

  2008cites this paper
• Randomised trials of Graft versus Host Disease prophylaxis in haemopoietic stem cell transplantation.

  2008cites this paper
• Current concepts in the pathogenesis and management of oral mucositis as a complication of cancer therapy

  2008cites this paper
• Acute Graft-versus-Host Disease

  2008cites this paper
• Cytotoxic treatment-induced gastrointestinal symptoms

  2007cites this paper
• Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?

  2007cites this paper
• Use of Recombinant Growth Factors after Hematopoietic Cell Transplantation

  2007cites this paper
• Updated clinical practice guidelines for the prevention and treatment of mucositis

  2007cites this paper
• Protection against chemotherapy induced mucositis by TGF‐β2 in childhood cancer patients: Results from a randomized cross‐over study

  2007cites this paper
• Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy.

  2007cites this paper
• Interventions for preventing oral mucositis for patients with cancer receiving treatment.

  2007cites this paper
• Mucositis in patients with hematologic malignancies: an overview.

  2007cites this paper
• Cancer treatment-induced oral mucositis.

  2007cites this paper
• Local administration of interleukin-11 ameliorates intestinal radiation injury in rats.

  2007cites this paper
• Acute Graft-Versus-Host Disease

  2006cites this paper
• Management of the Bone Marrow Transplant Patient

  2006cites this paper
• Shared biology of GVHD and GVT effects: potential methods of separation.

  2006cites this paper
• Modulation of the systemic inflammatory response by recombinant human interleukin-11: a prospective randomized placebo controlled clinical study in patients with hematological malignancy.

  2006cites this paper
• Interventions for preventing oral mucositis for patients with cancer receiving treatment.

  2006cites this paper
• Kapitel X4 – Ernährungsmedizinische Aspekte bei hämatopoetischer Stammzelltransplantation

  2006cites this paper
• Pathophysiology of graft-versus-host disease.

  2006cites this paper
• Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis

  2006cites this paper
• Immune restoration following hematopoietic stem cell transplantation: an evolving target

  2005cites this paper
• Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignancies.

  2005cites this paper
• Graft Versus Host Disease in Allogeneic Stem Cell Transplantation - 3 ½ Years Experience

  2005cites this paper
• Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.

  2005cites this paper
• The Pathophysiology of Acute Graft‐Versus‐Host Disease

  2005cites this paper
• Approaches to graft‐vs‐host disease

  2005cites this paper
• Graft versus host disease in allogeneic stem cell transplantation--3 1/2 years experience.

  2005cites this paper
• Ocular melanoma versus ocular metastasis: a diagnostic dilemma.

  2005cites this paper
• Pathophysiology of Acute Graft-vs-Host Disease

  2004cites this paper
• Recent advances in the treatment of graft-versus-host disease.

  2004cites this paper
• The Pathophysiology of Graft-vs.-Host Disease

  2004cites this paper
• Molecular monitoring of acute graft-versus-host disease after allogenic stem cell transplantation

  2004cites this paper
• Evidence-based guidelines for the management of neutropenia following outpatient hematopoietic stem cell transplantation.

  2004cites this paper
• Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant.

  2003cites this paper
• Drugs acting on the immune system

  2003cites this paper
• Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositis.

  2003cites this paper
• The effect of oral mucositis on morbidity and mortality in bone marrow transplant.

  2003cites this paper
• Analysis of sepsis in allogeneic bone marrow transplant recipients: a single-center study

  2003cites this paper